Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow An erratum has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (12)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Price, C. T. D.
Right arrow Articles by Gustafson, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Price, C. T. D.
Right arrow Articles by Gustafson, J. E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (1999) 44, 57-64
© 1999 The British Society for Antimicrobial Chemotherapy

Effects of salicylate and related compounds on fusidic acid MICs in Staphylococcus aureus

Christopher T. D. Price, Frances G. O'Brien, Bradley P. Shelton, John R. Warmington, Warren B. Grubb and John E. Gustafson*

Microbiology Group, School of Biomedical Sciences, Curtin University of Technology, GPO Box U1987, Perth 6845, Western Australia

Salicylate, acetyl-salicylate, benzoate and ibuprofen increased fusidic acid MICs for fusidic acid-resistant and -susceptible strains of Staphylococcus aureus representing six genetic lineages. The effects of these substances on fusidic acid resistance levels occurred in a strain-dependent manner. The weak acid acetate, and acetaminophen did not alter fusidic acid resistance levels, while the addition of saligenin, the alcohol of salicylate, reduced gradient plate MICs for all strains studied. These findings indicate that a benzoic acid structure is required for the induction of increased intrinsic fusidic acid resistance levels. When 2 mM salicylate was added to media used in population analyses, the number of cells able to survive on high concentrations of fusidic acid increased. This increase in cell survival was observed in two unrelated fusidic acid-resistant strains, with chromosomal (WBG8287) or plasmid (WBG1576) mediated resistance determinants and two unrelated susceptible strains. The salicylate-induced increase in fusidic acid resistance was phenotypic at low fusidic acid concentrations (relative to resistance phenotype) for WBG8287 and a fusidic acid-susceptible strain. On media containing salicylate and high fusidic acid concentrations, the mutation frequency to higher fusidic acid resistance levels was greater for WBG8287, compared with unsupplemented fusidic acid-containing media. These experiments provide evidence for a novel salicylate inducible fusidic acid resistance mechanism in S. aureus.

* Corresponding author. Tel: 61-8-9266-7434; Fax: 61-8-9266-2342; E-mail: tgustafs{at}alpha2.curtin.edu.au


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Antimicrob ChemotherHome page
A. Delgado, S. Zaman, A. Muthaiyan, V. Nagarajan, M. O. Elasri, B. J. Wilkinson, and J. E. Gustafson
The fusidic acid stimulon of Staphylococcus aureus
J. Antimicrob. Chemother., December 1, 2008; 62(6): 1207 - 1214.
[Abstract] [Full Text] [PDF]

Home page
 J. Bacteriol.Home page
J. T. Riordan, A. Muthaiyan, W. Van Voorhies, C. T. Price, J. E. Graham, B. J. Wilkinson, and J. E. Gustafson
Response of Staphylococcus aureus to Salicylate Challenge
J. Bacteriol., January 1, 2007; 189(1): 220 - 227.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. L. Johnston and R. J. Martin
Chlamydophila pneumoniae and Mycoplasma pneumoniae: A Role in Asthma Pathogenesis?
Am. J. Respir. Crit. Care Med., November 1, 2005; 172(9): 1078 - 1089.
[Abstract] [Full Text] [PDF]

Home page
 Mayo Clin Proc.Home page
J. P. Clark and E. Langston
Ketolides: A New Class of Antibacterial Agents for Treatment of Community-Acquired Respiratory Tract Infections in a Primary Care Setting
Mayo Clin. Proc., September 1, 2003; 78(9): 1113 - 1124.
[Abstract] [PDF]

Home page
 GutHome page
W H Wang, W M Wong, D Dailidiene, D E Berg, Q Gu, K C Lai, S K Lam, and B C Y Wong
Aspirin inhibits the growth of Helicobacter pylori and enhances its susceptibility to antimicrobial agents
Gut, April 1, 2003; 52(4): 490 - 495.
[Abstract] [Full Text] [PDF]

Home page
 Appl. Environ. Microbiol.Home page
C. T. D. Price, V. K. Singh, R. K. Jayaswal, B. J. Wilkinson, and J. E. Gustafson
Pine Oil Cleaner-Resistant Staphylococcus aureus: Reduced Susceptibility to Vancomycin and Oxacillin and Involvement of SigB
Appl. Envir. Microbiol., November 1, 2002; 68(11): 5417 - 5421.
[Abstract] [Full Text] [PDF]

Home page
 J Med MicrobiolHome page
C. T. D. PRICE and J. E. GUSTAFSON
Increases in the mutation frequency at which fusidic acid-resistant Staphylococcus aureus arise with salicylate
J. Med. Microbiol., January 1, 2001; 50(1): 104 - 106.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.